Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Renata Farkas"'
Autor:
Katharina A. Domnanich, Cristina Müller, Renata Farkas, Raffaella M. Schmid, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Abstract Background Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this study was to investigate the potential of usin
Externí odkaz:
https://doaj.org/article/426a2a03dc4a46d2ad31181509126f76
Autor:
Lauren L. Radford, Solana Fernandez, Rebecca Beacham, Retta El Sayed, Renata Farkas, Martina Benešová, Cristina Müller, Suzanne E. Lapi
Publikováno v:
Pharmaceuticals, Vol 12, Iss 4, p 166 (2019)
Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has
Externí odkaz:
https://doaj.org/article/ac93a934cfd341c19d6c83bf58bf122d
Autor:
Lajos Novak, Oscar Jiménez, Miguel A. Miranda, Carles Trullas, Olga Gorchs, Mercedesz Törincsi, Jordi Corbera, Virginie Lhiaubet-Vallet, Renata Farkas
Publikováno v:
Molecules, Vol 15, Iss 9, Pp 6205-6216 (2010)
Two new 2-(2´-hydroxyaryl)benzotriazole derivatives were synthesized and studied by photophysical and photochemical techniques in order to assess their ability to act as UV-filters. The absorption and emission properties of both compounds were deter
Externí odkaz:
https://doaj.org/article/1c93e951b2794891b1a3fc9aa09b10cf
Autor:
Martina Benešová, Lauren L. Radford, Rebecca Beacham, Retta El Sayed, Solana Fernandez, Renata Farkas, Cristina Müller, Suzanne E. Lapi
Publikováno v:
Pharmaceuticals, Vol 12, Iss 4, p 166 (2019)
Pharmaceuticals
Volume 12
Issue 4
Pharmaceuticals, 12 (4)
Pharmaceuticals
Volume 12
Issue 4
Pharmaceuticals, 12 (4)
Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has
Autor:
Lauren L, Radford, Solana, Fernandez, Rebecca, Beacham, Retta, El Sayed, Renata, Farkas, Martina, Benešová, Cristina, Müller, Suzanne E, Lapi
Publikováno v:
Pharmaceuticals
Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has
Autor:
Nicholas P, van der Meulen, Roger, Hasler, Alain, Blanc, Renata, Farkas, Martina, Benešová, Zeynep, Talip, Cristina, Müller, Roger, Schibli
Publikováno v:
Journal of labelled compoundsradiopharmaceuticals. 62(8)
EnrichedReproducible results were obtained, yielding 3.6 to 8.3 GBqThe chemical separation devised to produce high-quality
Autor:
Cristina Müller, Simon M. Ametamey, Klaudia Siwowska, Roger Schibli, Renata Farkas, Nicholas P. van der Meulen
Publikováno v:
Molecular Pharmaceutics. 13:1979-1987
A number of folate-based radioconjugates have been synthesized and evaluated for nuclear imaging purposes of folate receptor (FR)-positive tumors and potential therapeutic application. A common shortcoming of radiofolates is, however, a significant a
Autor:
Martina Benešová, Cristina Müller, Roger Schibli, Raffaella M. Schmid, Francesca Borgna, Renata Farkas
Publikováno v:
Bioconjugate Chemistry, 28 (9)
The development of (radio)pharmaceuticals with favorable pharmacokinetic profiles is crucial for allowing the optimization of the imaging or therapeutic potential and the minimization of undesired side effects. The aim of this study was, therefore, t
Autor:
Katharina Anna Domnanich, Nicholas P. van der Meulen, Cristina Müller, Bernard Ponsard, Renata Farkas, Raffaella M. Schmid, Andreas Türler, Roger Schibli
Publikováno v:
Domnanich, Katharina Anna; Müller, Cristina; Farkas, Renata; Schmid, Raffaella M.; Ponsard, Bernard; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2016). 44Sc for labeling of DOTA-and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 8. Springer 10.1186/s41181-016-0013-5
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
Background Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this study was to investigate the potential of using NODAGA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44e6afce732d278b4ca4e0d12b16f01
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
Publikováno v:
Radiotherapy and Oncology. 118